NCT00741845View on ClinicalTrials.gov

Prevention of Persistence of Bacterial Vaginosis

PHASE3TerminatedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2009

Conditions
Bacterial Vaginosis
Interventions
DRUG

intravaginal metronidazole

high dose intravaginal metronidazole 750mg (with or without miconazole) to be compared to low dose intravaginal metronidazole 37.5mg

Trial Locations (1)

Unknown

Cayetano Heredia Hospital, Lima

Sponsors
All Listed Sponsors
lead

Embil Pharmaceutical Co. Ltd

INDUSTRY

NCT00741845 - Prevention of Persistence of Bacterial Vaginosis | Biotech Hunter | Biotech Hunter